These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8053695)

  • 1. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
    Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
    Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
    Szekeres L; Korom I
    Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic nevi and malignant melanoma.
    Crutcher WA; Cohen PJ
    Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
    de Snoo FA; Kroon MW; Bergman W; ter Huurne JA; Houwing-Duistermaat JJ; van Mourik L; Snels DG; Breuning MH; Willemze R; Frants RR; Gruis NA
    J Am Acad Dermatol; 2007 May; 56(5):748-52. PubMed ID: 17276542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neonatal phototherapy on melanocytic nevus count in children.
    Matichard E; Le Hénanff A; Sanders A; Leguyadec J; Crickx B; Descamps V
    Arch Dermatol; 2006 Dec; 142(12):1599-604. PubMed ID: 17178986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysplastic nevus syndrome of familial type. A family study].
    Grimstvedt MB
    Tidsskr Nor Laegeforen; 1992 Mar; 112(7):869-72. PubMed ID: 1557751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
    Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
    Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.
    Haenssle HA; Korpas B; Hansen-Hagge C; Buhl T; Kaune KM; Johnsen S; Rosenberger A; Schön MP; Emmert S
    Arch Dermatol; 2010 Mar; 146(3):257-64. PubMed ID: 20231495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
    Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
    Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.